A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1

Genomics

Volumn 73, Issue 3, 2001, Pages 243-254

  Watt, Fujiko ^a   Martorana, Anna ^a   Brookes, Diana E ^a   Ho, Thu ^a   Kingsley, Elizabeth ^b,c   O'Keefe, Denise S ^d   Russell, Pamela J ^b,c   Heston, Warren D W ^d   Molloy, Peter L ^a  

^a CSIRO   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DNA FRAGMENT; GAMMA GLUTAMYL HYDROLASE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROTEIN FOLH1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; COSMID; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MAPPING; GENE SEQUENCE; GENE STRUCTURE; GENE THERAPY; GENETIC ANALYSIS; HORMONAL REGULATION; HUMAN; HUMAN CELL; INTRON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION;

EID: 0035339157     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6446     Document Type: Article

References (46)

1. Aarnisalo P., Palvimo J. J., Janne O. A. CREB-binding protein in androgen receptor-mediated signaling. Proc. Natl. Acad. Sci. USA. 95:1998;2122-2127.
2. Brookes D. E., Zandvliet D., Watt F., Russell P. J., Molloy P. L. Relative activity and specificity of promoters from prostate-expressed genes. Prostate. 35:1998;18-26.
3. Burgos-Trinidad M., Youngblood G. L., Maroto M. R., Scheller A., Robins D. M., Payne A. H. Repression of cAMP-induced expression of the mouse P450 17α-hydroxylase/C17-20 lyase gene (Cyp17) by androgens. Mol. Endocrinol. 11:1997;87-96.
4. Cairns C., Cairns W., Okret S. Inhibition of gene expression by steroid hormone receptors via a negative glucocorticoid response element: Evidence for the involvement of DNA-binding and antagonistic effects of the antiglucocorticoid/antiprogestin RU486. DNA Cell Biol. 12:1993;695-702.
5. Carter R. E., Feldman A. R., Coyle J. T. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc. Natl. Acad. Sci. USA. 93:1996;749-753.
6. Chang S. S., Reuter V. E., Heston W. D. W., Bander N. H., Grauer L. S., Gaudin P. B. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumour-associated neovasculature. Cancer Res. 59:1999;3192-3198.
7. Cleutjens K. B. J. M., Vaneekelen C. C. E. M., Vanderkorput H. A. G. M., Brinkmann A. O., Trapman J. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J. Biol. Chem. 271:1996;6379-6388.
8. Cleutjens K. B. J. M., Vanderkorput H. A. G. M., van Eekelen C. C. E. M., van Rooij H. C. J., Faber P. W., Trapman J. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol. 11:1997;148-161.
9. Fair W. R., Israeli R. S., Heston W. D. W. Prostate-specific membrane antigen. Prostate. 32:1997;140-148.
10. Fronsdal K., Engedal N., Slagsvold T., Saatcioglu F. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J. Biol. Chem. 273:1998;31853-31859.
11. Good D., Schwartzenberger P., Eastham J. A., Rhoads R. E., Hunt J. D., Collins M., Batzer M., Theodossiou C., Kolls J. K., Grimes S. R. Cloning and characterization of the prostate-specific membrane antigen promoter. J. Cell. Biochem. 74:1999;395-405.
12. Greenberg N. M., Demayo F. J., Sheppard P. C., Barrios R., Lebovitz R., Finegold M., Angelopoulou R., Dodd J. G., Duckworth M. L., Rosen J. M., Matusik R. J. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol. 8:1994;230-239.
13. Heckert L. L., Wilson E. M., Nilson J. H. Transcriptional repression of the alpha-subunit gene by androgen receptor occurs independently of DNA binding but requires the DNA-binding and ligand-binding domains of the receptor. Mol. Endocrinol. 11:1997;1497-1506.
14. Horoszewicz J. S., Kawinski E., Murphy G. P. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostate cancer patients. Anticancer Res. 7:1987;927-936.
15. Israeli R. S., Powell C. T., Fair W. R., Heston W. D. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res. 53:1993;227-230.
16. Israeli R. S., Powell C. T., Corr J. G., Fair W. R., Heston W. D. W. Expression of the prostate-specific membrane antigen. Cancer Res. 54:1994;1807-1811.
17. Kallio P. J., Poukka H., Moilanen A., Janne O. A., Palvimo J. J. Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol. Endocrinol. 9:1995;1017-1028.
18. Kasper S., Rennie P. S., Bruchovsky N., Sheppard P. C., Cheng H., Lin L., Shiu R. P. C., Snoek R., Matusik R. J. Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J. Biol. Chem. 269:1994;31763-31769.
19. Klein K. A., Reiter R. E., Redula J., Moradi H., Xhu X. L., Brothman A. R., Lamb D. J., Marcelli M., Belldegrun A., Witte O. N., Sawyers W. L. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat. Med. 4:1997;402-408.
20. Leek J., Lench N., Maraj B., Bailey A., Carr I. M., Andersen S., Cross J., Whelan P., MacLennan K. A., Meridith D. M., Markham A. F. Prostate-specific membrane antigen: Evidence for the existence of a second related gene. Br. J. Cancer. 72:1995;583-588.
21. Liu H., Moy P., Kim S., Xia Y., Rajasekaran A., Navarro V., Knudsen B., Bander N. H. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res. 57:1997;3629-3634.
22. Lopes D., Davis W. L., Rosenstraus M. J., Uveges A. J., Gilman S. C. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from the antiprostate monoclonal antibody 7E11-C5. Cancer Res. 50:1990;6423-6429.
23. Murphy G. P., Tino W. J., Holmes E. H., Boynton A. L., Erikson S. J., Bowes V. A., Barren R. J., Tjoa B. A., Misrock S. L., Ragde H., Kenny G. M. Measurement of prostate-specific membrane antigen in the serum with a new antibody. Prostate. 28:1996;266-271.
24. ++ mobilization on expression of androgen-regulated genes: Interference with androgen receptor-mediated transactivation by AP-1 proteins. Prostate. 33:1997;264-270.
25. O'Keefe D. S., Su S. L., Bacich D. J., Horiguchi Y., Luo Y., Powell C. T., Zandvliet D., Russell P. J., Molloy P. L., Nowak N. J., Shows T. B., Mullins C., Vonder Haar R. A., Fair W. R., Heston W. D. W. Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim. Biophys. Acta. 1443:1998;113-127.
26. O'Keefe D. S., Uchida A., Bacich D. J., Watt F., Martorana A., Molloy P. L., Heston W. D. W. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer. Prostate. 45:2000;149-157.
27. Pang S., Taneja S., Dardashti K., Cohan P., Kaboo R., Sokoloff M., Tso C. L., Dekernion J. B., Belldegrun A. S. Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Hum. Gene Ther. 6:1995;1417-1426.
28. Pinto J. T., Suffoletto B. P., Berzin T. M., Qiao C. H., Lin S., Tong W. P., May F., Mukherjee B., Heston W. D. W. Prostate-specific membrane antigen: A novel folate hydrolase in human prostatic carcinoma cells. Clin. Cancer Res. 2:1996;1445-1451.
29. Renneberg, H, Friedetzky, A, Konrad, L, Kurek, R, Weingartner, K, Wennemuth, G, Tunn, U. W, and, Aumuller, G. 1999, Prostate specific antigen (PSM) is expressed in various human tissues: Implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread.
30. Rennie P. S., Bruchovsky N., Leco K. J., Sheppard P. C., McQueen S. A., Cheng H., Snoek R., Hamel A., Bock M. E., MacDonald B. S., Nickel B. E., Chang C., Liao S., Cattini P. A., Matusik R. J. Characterization of two cis-acting DNA elements involved in the regulation of the probasin gene. Mol. Endocrinol. 7:1993;23-36.
31. Riegman P. H. J., Vlietstra R. J., van der Korput J. A. G. M., Brinkman A. O., Trapman J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol. 5:1991;1921-1930.
32. Rinker-Schaeffer C. W., Hawkins A. L., Su S. L., Israeli R. S., Griffin C. A., Isaacs J. T., Heston W. D. W. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. Genomics. 30:1995;105-108.
33. Sato N., Sadar M. D., Bruchovsky N., Saatcioglu F., Rennie P. S., Sato S., Lange P. H., Gleave M. E. Androgenic induction of prostate-specific antigen is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cell line LNCaP. J. Biol. Chem. 272:1997;17485-17494.
34. Schaffner D. L., Barrios R., Shaker M. R., Rajagopalan S., Huang S. L., Tindall D. J., Young C. Y. F., Overbeek P. A., Lebovitz R. M., Lieberman M. W. Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms. Lab. Invest. 72:1995;283-290.
35. Schuur E. R., Henderson G. A., Kmetec L. A., Miller J. D., Lamparski H. G., Henderson D. R. Prostate-specific antigen expression is regulated by an upstream enhancer. J. Biol. Chem. 271:1996;7043-7051.
36. Silver D. A., Pellicer I., Fair W. R., Heston W. D. W., Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant tissues. Clin. Cancer Res. 3:1997;81-85.
37. Song C. S., Jung M. H., Kim S. C., Hassan T., Roy A. K. Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter. J. Biol. Chem. 273:1998;21856-21866.
38. Su S. L., Huang I. P., Fair W. R., Heston W. D. W. Alternatively spliced variants of prostate-specific membrane antigen RNA: Ratio of expression as a potential measurement of progression. Cancer Res. 55:1995;1441-1443.
39. Tricoli J. V., Yao J. L., D'Souza S. A., Bracken R. B. Detection of sex-region Y (SRY) transcripts in human prostate adenocarcinoma and benign prostatic hypertrophy. Genes Chromosomes Cancer. 8:1993;28-33.
40. Troyer J. K., Beckett M. L., Wright G. L. Jr. Location of the prostate specific membrane antigen in the LNCaP prostate carcinoma cell line. Prostate. 30:1997;232-242.
41. Troyer J. K., Feng Q., Beckett M. L., Wright G. L. Jr. Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate specific membrane antigen. Urol. Oncol. 1:1995;29-37.
42. Wegner M. From head to toes: The multiple facets of Sox proteins. Nucleic Acids Res. 27:1999;1409-1420.
43. Wright G. L., Haley C., Beckett M. L., Schellhammer P. F. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol. Oncol. 1:1995;16-28.
44. Wright G. L. Jr., Grob M., Haley C., Grossman K., Newhall K., Petrylak D., Troyer J., Konchuba A., Schellhammer P. F., Moriarty R. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology. 48:1996;326-334.
45. Yan Y., Sheppard P. C., Kasper S., Lin L., Hoare S., Kapoor A., Dodd J. G., Duckworth M. L., Matusik R. J. Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice. Prostate. 32:1997;129-139.
46. Yu D. C., Sakamoto G. T., Henderson D. R. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. Cancer Res. 59:1999;1498-1504.